Roberto N Miranda Selected Research

Asbestos

10/2022

Localized Malignant Peritoneal Mesothelioma (LMPeM) in Women: A Clinicopathologic Study of 18 Cases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roberto N Miranda Research Topics

Disease

49	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 03/2024 - 04/2012
41	Neoplasms (Cancer) 03/2024 - 10/2004
30	Lymphoma (Lymphomas) 02/2024 - 08/2011
19	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 07/2012
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2023 - 01/2011
8	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2023 - 03/2010
8	Disease Progression 01/2022 - 01/2013
7	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023 - 11/2012
4	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 09/2022 - 06/2013
4	Blast Crisis (Blast Phase) 01/2020 - 03/2011
4	Seroma 01/2020 - 01/2017
3	Lymphadenopathy 03/2024 - 03/2012
3	Mycosis Fungoides 02/2024 - 01/2016
3	Fibrosis (Cirrhosis) 10/2021 - 10/2003
3	Eosinophilia 01/2021 - 09/2015
3	Inflammation (Inflammations) 01/2020 - 05/2005
3	Chromosome Aberrations (Chromosome Abnormalities) 12/2017 - 04/2010
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2017 - 03/2011
3	Large Granular Lymphocytic Leukemia 01/2017 - 10/2015
3	Infections 12/2016 - 12/2006
2	Multiple Myeloma 11/2022 - 08/2011
2	Hypoxia (Hypoxemia) 01/2021 - 10/2017
2	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 01/2019
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 09/2020 - 05/2016
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 08/2011
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019 - 02/2017
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 08/2011
2	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 02/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2016 - 03/2011
2	Thrombocytopenia (Thrombopenia) 11/2015 - 12/2002
2	Genetic Translocation (Chromosomal Translocation) 12/2014 - 04/2010
2	Epstein-Barr Virus Infections 08/2014 - 08/2013
1	Rupture 03/2024
1	Pathologic Complete Response 12/2023
1	Granuloma 01/2023
1	Sinus Histiocytosis (Rosai-Dorfman Disease) 01/2022
1	Foreign Bodies (Foreign Body) 10/2021
1	Contracture 05/2021
1	Residual Neoplasm 01/2021
1	Rare Diseases (Rare Disease) 06/2020
1	Primary Effusion Lymphoma 04/2020
1	Burns 01/2020
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2020

Drug/Important Bio-Agent (IBA)

11	Capsules (Microcapsules)IBA 06/2023 - 07/2012
8	Anaplastic Lymphoma KinaseIBA 06/2022 - 09/2009
7	Rituximab (Mabthera)FDA Link 12/2023 - 01/2011
6	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018 - 07/2012
5	Proteins (Proteins, Gene)FDA Link 02/2024 - 02/2013
5	AntigensIBA 01/2022 - 06/2013
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 01/2011
4	Vincristine (Oncovin)FDA LinkGeneric 12/2023 - 01/2011
4	Cyclin D1IBA 01/2023 - 04/2002
4	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2021 - 09/2015
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 12/2012
4	CytokinesIBA 01/2020 - 12/2016
3	Prednisone (Sone)FDA LinkGeneric 12/2023 - 01/2011
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
3	Phosphotransferases (Kinase)IBA 01/2021 - 10/2012
3	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 12/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 01/2011
2	ChromatinIBA 01/2023 - 10/2004
2	SiliconesIBA 10/2021 - 12/2020
2	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2012
2	Immunoglobulin M (IgM)IBA 09/2020 - 05/2016
2	Phenobarbital (Luminal)FDA Link 01/2020 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2015
2	ibrutinibIBA 01/2020 - 02/2016
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 08/2016
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2020 - 12/2012
2	Interleukin-13IBA 01/2020 - 01/2018
2	Bortezomib (Velcade)FDA Link 10/2017 - 02/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2017 - 08/2013
2	Azathioprine (Imuran)FDA LinkGeneric 02/2017 - 08/2013
2	Granzymes (Granzyme)IBA 02/2017 - 11/2012
2	Methotrexate (Mexate)FDA LinkGeneric 11/2015 - 08/2013
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2015 - 04/2010
2	Tyrosine (L-Tyrosine)FDA Link 12/2014 - 10/2012
2	Thalidomide (Thalomid)FDA Link 12/2014 - 08/2013
2	Serine (L-Serine)FDA Link 10/2012 - 08/2011
1	PlasticsIBA 02/2024
1	Glia Maturation Factor (GMF)IBA 02/2024
1	CyclinsIBA 12/2023
1	NF-kappa B (NF-kB)IBA 11/2023
1	Interferon Regulatory FactorsIBA 11/2022
1	AsbestosIBA 10/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022
1	Immune Checkpoint ProteinsIBA 01/2021
1	Interleukin-22 (IL-22)IBA 01/2020
1	Interleukin-9 (Interleukin 9)IBA 01/2020
1	ChemokinesIBA 01/2020
1	LigandsIBA 01/2020
1	InterferonsIBA 01/2020

Therapy/Procedure

48	Breast Implants (Breast Implant) 03/2024 - 09/2009
25	Therapeutics 01/2023 - 12/2002
10	Drug Therapy (Chemotherapy) 12/2023 - 03/2012
3	Splenectomy 01/2017 - 11/2012
1	Stem Cell Transplantation 01/2023
1	Organ Transplantation 01/2020
1	Immunotherapy 01/2020